| Sean Craig Stout, MD | |
|
901 N Curtis Rd Ste 100, Boise, ID 83706-1339 | |
| (208) 378-0080 | |
| Not Available |
| Full Name | Sean Craig Stout |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 7 Years |
| Location | 901 N Curtis Rd Ste 100, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417488131 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| St Luke's Nampa Medical Center | Nampa, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boise Valley Asthma And Allergy Pa | 6901860014 | 7 |
News Archive
Patients with chest pain have similar rates of heart attacks and other major cardiac events within two years whether they were evaluated with a new type of CT scan or the traditional stress test, according to results presented today by Duke Medicine researchers at a meeting of the American College of Cardiology.
The latest cardiovascular disease (CVD) prevention guidelines have been overhauled to produce a user friendly document with concise messages that awards greater weight than ever before to evidence from clinical trials and observational population studies. The "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012)" - were launched at the EuroPRevent2012 meeting in Dublin, Ireland.
ViviGen Cellular Bone Matrix, an innovative cellular allograft developed by LifeNet Health and marketed in collaboration with DePuy Synthes Spine, received one of the highest honors in spinal medicine, Orthopedics This Week's Best New Technology in Spine award.
As part of its commitment to providing the highest quality of care to the community, Tower Hematology Oncology Medical Group has announced the formation of Tower Oncology's Cancer Support Network.
The Epilepsy Therapy Project, a non-profit organization dedicated to accelerating new therapies for people living with epilepsy, today released presentation highlights following its successful 2010 Epilepsy Pipeline Update Conference held in San Francisco. Sponsored by ETP, this conference brings together leading clinical investigators, emerging CNS companies and academic innovators with investors and business development partners to facilitate professional collaboration, funding and partnerships that will accelerate patient access to new treatments.
› Verified 3 days ago
| Entity Name | Boise Valley Asthma & Allergy Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215061734 PECOS PAC ID: 6901860014 Enrollment ID: O20041118000313 |
News Archive
Patients with chest pain have similar rates of heart attacks and other major cardiac events within two years whether they were evaluated with a new type of CT scan or the traditional stress test, according to results presented today by Duke Medicine researchers at a meeting of the American College of Cardiology.
The latest cardiovascular disease (CVD) prevention guidelines have been overhauled to produce a user friendly document with concise messages that awards greater weight than ever before to evidence from clinical trials and observational population studies. The "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012)" - were launched at the EuroPRevent2012 meeting in Dublin, Ireland.
ViviGen Cellular Bone Matrix, an innovative cellular allograft developed by LifeNet Health and marketed in collaboration with DePuy Synthes Spine, received one of the highest honors in spinal medicine, Orthopedics This Week's Best New Technology in Spine award.
As part of its commitment to providing the highest quality of care to the community, Tower Hematology Oncology Medical Group has announced the formation of Tower Oncology's Cancer Support Network.
The Epilepsy Therapy Project, a non-profit organization dedicated to accelerating new therapies for people living with epilepsy, today released presentation highlights following its successful 2010 Epilepsy Pipeline Update Conference held in San Francisco. Sponsored by ETP, this conference brings together leading clinical investigators, emerging CNS companies and academic innovators with investors and business development partners to facilitate professional collaboration, funding and partnerships that will accelerate patient access to new treatments.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean Craig Stout, MD 901 N Curtis Rd Ste 100, Boise, ID 83706-1339 Ph: (208) 378-0080 | Sean Craig Stout, MD 901 N Curtis Rd Ste 100, Boise, ID 83706-1339 Ph: (208) 378-0080 |
News Archive
Patients with chest pain have similar rates of heart attacks and other major cardiac events within two years whether they were evaluated with a new type of CT scan or the traditional stress test, according to results presented today by Duke Medicine researchers at a meeting of the American College of Cardiology.
The latest cardiovascular disease (CVD) prevention guidelines have been overhauled to produce a user friendly document with concise messages that awards greater weight than ever before to evidence from clinical trials and observational population studies. The "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012)" - were launched at the EuroPRevent2012 meeting in Dublin, Ireland.
ViviGen Cellular Bone Matrix, an innovative cellular allograft developed by LifeNet Health and marketed in collaboration with DePuy Synthes Spine, received one of the highest honors in spinal medicine, Orthopedics This Week's Best New Technology in Spine award.
As part of its commitment to providing the highest quality of care to the community, Tower Hematology Oncology Medical Group has announced the formation of Tower Oncology's Cancer Support Network.
The Epilepsy Therapy Project, a non-profit organization dedicated to accelerating new therapies for people living with epilepsy, today released presentation highlights following its successful 2010 Epilepsy Pipeline Update Conference held in San Francisco. Sponsored by ETP, this conference brings together leading clinical investigators, emerging CNS companies and academic innovators with investors and business development partners to facilitate professional collaboration, funding and partnerships that will accelerate patient access to new treatments.
› Verified 3 days ago
George William Palmer, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd, Ste 100, Boise, ID 83706 Phone: 208-378-0080 Fax: 208-378-0259 | |
John D Jeppson, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd, Suite 100, Boise, ID 83706 Phone: 208-378-0080 Fax: 208-378-0259 | |
Charles Nephi Webb, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Curtis Rd, Ste 303, Boise, ID 83706 Phone: 208-377-4000 Fax: 208-375-8426 | |
Michael V Keiley, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd, Ste 100, Boise, ID 83706 Phone: 208-378-0080 Fax: 208-378-0259 |